Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors
about
Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate actionPharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)Alcohol and the prefrontal cortexDifferential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological AlterationsPharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.From Clinical Application to Cognitive Enhancement: The Example of MethylphenidateSingle exposure of dopamine D1 antagonist prevents and D2 antagonist attenuates methylphenidate effectFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation.Acute administration of methylphenidate alters the prefrontal cortex neuronal activity in a dose-response characteristic.Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorderCannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortexEffect of antidepressant drugs on the vmPFC-limbic circuitryThe effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adultsDistinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors.Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.Functional neuroanatomy of the central noradrenergic system.ADHD pharmacogenetics across the life cycle: New findings and perspectives.Update on 3-iodothyronamine and its neurological and metabolic actions.Stress Response, Brain Noradrenergic System and Cognition.Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i.Age-dependent effects of methylphenidate in the prefrontal cortex: evidence from electrophysiological and Arc gene expression measurements.Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children.Noradrenaline Modulates the Membrane Potential and Holding Current of Medial Prefrontal Cortex Pyramidal Neurons via β1-Adrenergic Receptors and HCN Channels.Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.Noradrenergic fiber sprouting and altered transduction in neuropathic prefrontal cortex.Dysregulation of gene induction in corticostriatal circuits after repeated methylphenidate treatment in adolescent rats: differential effects on zif 268 and homer 1a.Dopamine D1/5 receptor-mediated long-term potentiation of intrinsic excitability in rat prefrontal cortical neurons: Ca2+-dependent intracellular signaling.Activation of 5-HT receptors inhibits GABAergic transmission by pre-and post-synaptic mechanisms in layer II/III of the juvenile rat auditory cortex.Methylphenidate (MPH) promotes visual cortical activation in healthy adults in a cued visuomotor task.Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents.
P2860
Q21090824-7B784D9F-80BE-4FBF-A0D1-8DA3F53555AFQ22251113-256F240A-3440-4159-9D24-B874E5B70278Q24608362-59EDFF5C-9912-4C9F-8A09-5E9FF3078F8FQ27310934-A347B5AB-D945-4315-8552-03AC3605F901Q27687469-10A30A68-0BAC-446A-875E-48D819817B20Q28073785-E172360D-BF7D-4313-817D-CD6FA0E10458Q28275563-C9AD2205-A51A-4F89-AA43-575357072903Q30489125-C6A86F97-CB00-44A8-B415-399CAAB84E21Q33679327-F97657F3-921E-4CB9-A3B7-DC432F51978DQ33870580-361CE7C0-8467-419F-9E4A-EE7752B4C149Q34221423-4BCFFF02-C9F7-48CB-84C5-7A5E2D9332F5Q34381331-FCFBBC42-8308-4EEB-8B8D-5AD398E63A05Q35137628-4AF61311-7435-4129-82EA-C18177E0E312Q35864146-343F6F0D-212C-4F38-835F-1681621EA0D1Q36208021-9EF6FA3F-6A4E-4D00-938C-DDD306B2AB3AQ36446854-48A4125B-F710-46CF-BB97-D73A9C418D01Q37010911-DC4CA6F4-19B7-41C0-9910-72E285AB0854Q37143837-127B2411-4DAA-409B-BD5F-8123FF19F841Q37220477-2A002227-7E17-4AB1-A962-A22F5479FEC5Q37529127-4AC350BD-ED97-42C9-BB15-CE0A8CB67306Q38029532-B7BDCD89-20EB-49EC-90EB-DC7F83B51C16Q38114027-75F149CA-80D5-4889-81A0-72E1BAFB04E3Q38209972-A5B17076-E0E0-47A0-9AAD-F67A6F93A215Q38264120-B49DA642-D908-4F64-BDCB-32CF91480504Q38764702-1177A8D8-7E3C-4052-975A-FF6659BBD4D1Q38877585-0047B2BF-D1DD-43D9-ABD4-0EF94698B44DQ39616634-A3F172BF-A911-40D1-92AD-BB4FF0CBF7EAQ42256211-C672E093-28E3-4A06-9B2C-5AE0E336AE1DQ43168363-58B7524E-6D71-40C8-8026-4015A006AD3FQ43429050-2D9422ED-4A4C-40E1-B83F-320F43491CB5Q47325822-94592307-22FC-4A61-9788-F602D60BFCE6Q47326953-E7A64928-CE3B-4B29-AC60-F0E4A9288381Q47990864-BB7B17FB-6972-44F1-A70E-4C4425804192Q48116660-283C9316-591B-4881-8CBE-92B1B3FE40A0Q48307009-41739D2E-3711-4DBA-BCEE-88697F694FB3Q48421558-37E4D1B6-315E-45A7-BC97-7C46428E3B83Q48592026-FCC657E2-CF99-4D29-9434-F790303F6773Q50800347-289A7578-35F0-4EF2-BED8-9BA3F223DE63Q51972660-38DA7180-3989-41D1-B43D-4631C15ECB0E
P2860
Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Methylphenidate increases cort ...... lpha-2 noradrenergic receptors
@ast
Methylphenidate increases cort ...... lpha-2 noradrenergic receptors
@en
type
label
Methylphenidate increases cort ...... lpha-2 noradrenergic receptors
@ast
Methylphenidate increases cort ...... lpha-2 noradrenergic receptors
@en
prefLabel
Methylphenidate increases cort ...... lpha-2 noradrenergic receptors
@ast
Methylphenidate increases cort ...... lpha-2 noradrenergic receptors
@en
P2860
P356
P1476
Methylphenidate increases cort ...... lpha-2 noradrenergic receptors
@en
P2093
Antonieta Lavin
Glenn D Andrews
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300818
P407
P577
2006-03-01T00:00:00Z
P5875
P6179
1012448195